Cytokine Profiles Could a Priori Predict Response to SSRIs in Medication-Naïve Patients with Major Depressive Disorder

Simple item page
dc.contributor.authorAmani Bashar Ahmed
dc.contributor.authorRahmeh Y. Natsheh
dc.contributor.authorOday M. Abushalbaq
dc.contributor.authorHussain Y. Khdour
dc.contributor.authorMahmud A. Sehwail
dc.contributor.authorMohmmad M. Herzallah
dc.date.accessioned2022-06-22T11:43:29Z
dc.date.available2022-06-22T11:43:29Z
dc.date.issued2022-05-11
dc.description.abstractBackground: Major depressive disorder (MDD) is one of the most prevalent psychiatric disorders in Palestine. It manifests as symptoms of depressed mood and loss of interest in daily life activities. The “Cytokine Hypothesis of Depression” argues that MDD results from an imbalance between pro- and anti-inflammatory cytokines. Only 30% of patients with MDD respond to treatment with SSRI antidepressants.
dc.identifier.urihttps://hdl.handle.net/20.500.12213/6591
dc.language.isoen
dc.publisherAl-Quds University, Deanship of Scientific Research
dc.titleCytokine Profiles Could a Priori Predict Response to SSRIs in Medication-Naïve Patients with Major Depressive Disorder
dc.typeArticle
dspace.entity.type
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cytokine Profiles Could a Priori Predict Response to SSRIs in Medication-Naïve Patients with Major Depressive Disorder.pdf
Size:
414.24 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.61 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Neuroscience